Ahead of strate­gic up­date, new Sanofi CEO mulls op­tions for con­sumer health­care arm — re­ports

Big phar­ma has made moves to sharp­en its fo­cus on de­vel­op­ing new med­i­cines, while slow-grow­ing con­sumer health di­vi­sions fall by the way­side. Looks like an­oth­er large drug­mak­er is con­sid­er­ing a sim­i­lar move. On Thurs­day, re­ports cit­ing sources in­di­cat­ed that Sanofi is re­port­ed­ly mulling a joint ven­ture, sale, or a pub­lic list­ing of its con­sumer health arm.

The French group is in dis­cus­sions for op­tions that could val­ue the di­vi­sion at $30 bil­lion, Bloomberg and Reuters re­port­ed, cit­ing sources fa­mil­iar with the mat­ter.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER